PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cancer 1,053,491 Disease Target A1AT 329 34 0.00 -0.95 0.10 0.55
CEA 17,022 Target Target A1AT 329 8 0.00 -0.99 0.02 0.62
CD68 6,424 Target Target A1AT 329 2 0.00 -1.00 0.01 0.61
CD4 112,219 Target Target A1AT 329 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
CCL18 256 Target Target A1AT 329 2 0.01 -0.99 0.01 0.72
C5a 4,164 Target Target A1AT 329 1 0.00 -1.00 0.00 0.60
Bronchitis 18,336 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.60
Bladder Cancer 21,509 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.59
BNP 6,842 Target Target A1AT 329 1 0.00 -1.00 0.00 0.59
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
Adult Respiratory Distress Syndrome 4,034 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.62
Adiponectin 11,994 Target Target A1AT 329 2 0.00 -1.00 0.01 0.59
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
AFP 9,751 Target Target A1AT 329 11 0.01 -0.98 0.03 0.65
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Schizophrenia 77,034 Disease Target 5-Hydroxytryptamine 2a Receptor 67 10 0.00 -0.92 0.15 0.61
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Platelet Aggregation 25,460 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.61
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Obesity 138,233 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.56
Insomnia 12,434 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.63
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Hyperglycemia 28,168 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.60
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Depression 220,092 Disease Target 5-Hydroxytryptamine 2a Receptor 67 5 0.00 -0.96 0.07 0.57
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Hepatitis B 57,815 Disease Drug 4-Mercaptobenzoic Acid 70 2 0.00 -0.99 0.03 0.58
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
4-Mercaptopyridine 96 Drug Drug 4-Mercaptobenzoic Acid 70 2 0.02 -0.98 0.03 0.79
Graft Versus Host Disease 15,741 Disease Target 4-1BB Receptor 20 2 0.00 -0.95 0.10 0.63
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Infection 766,637 Disease Target 4-1BB Ligand 135 11 0.00 -0.96 0.08 0.55
Graft Versus Host Disease 15,741 Disease Target 4-1BB Ligand 135 2 0.00 -0.99 0.01 0.60
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Carcinoma 433,099 Disease Target 4-1BB Ligand 135 14 0.00 -0.95 0.10 0.57
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
CEA 17,022 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.58
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
CD1A 2,739 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.63
CD14 9,941 Target Target 4-1BB Ligand 135 3 0.00 -0.99 0.02 0.63
BAFF 1,240 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.65
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
Non Small Cell Lung Cancer 28,563 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.58
Lung Cancer 91,416 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 4 0.00 -0.99 0.02 0.56
Epidermal Growth Factor Receptor 24,772 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 3 0.00 -0.99 0.01 0.59
Diabetes 332,602 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 9 0.00 -0.98 0.04 0.55
Colon Cancer 30,064 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.57
CD4 112,219 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 1 0.00 -1.00 0.00 0.53
Stroke 146,992 Disease Target 11-Beta-Hydroxylase 721 6 0.00 -1.00 0.01 0.54
Steroid 5-Alpha-Reductase 293 Target Target 11-Beta-Hydroxylase 721 4 0.01 -0.99 0.01 0.71
Shock 134,031 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.53
Sepsis 64,798 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Sedation 27,984 Disease Target 11-Beta-Hydroxylase 721 3 0.00 -1.00 0.00 0.56
Renin 43,456 Target Target 11-Beta-Hydroxylase 721 55 0.01 -0.96 0.08 0.64
Renal Failure 73,993 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Prostate Cancer 71,064 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Platelet Activating Factor 9,915 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Pain 409,851 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.48
Obesity 138,233 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.52